Skip to main content

April 17, 2023

Presentation: Qualitative methods identify functional abilities goals for children with SCN2A Associated Developmental and Epileptic Encephalopathy

The presentation highlighted the use of Goal Attainment Scaling (GAS) to capture meaningful changes

Our CEO, Chere Chapman, participated in the symposium, Capturing Inchstones: Novel Approaches to Measurement for Severely Affected Children With SCN2A-Associated Developmental and Epileptic Encephalopathy, at the 55th annual Gatlinburg Conference. The presentation highlighted qualitative approaches, including Goal Attainment Scaling (GAS), to understand what’s important to families and how they define meaningful change.

Contact Us

Local with a global impact

Based in Nova Scotia, our culture reflects an East Coast Canadian ethos rooted in hard work and collegiality.

With over a decade of experience partnering with multinational sponsors on cutting-edge patient-centric research, the impact of our work is global.

Follow us for more: